American Ventures is funding the ConMRx platform rollout to scale infectious disease detection. This capital infusion aims to secure key government contracts.
Alpha Score of 49 reflects weak overall profile with moderate momentum, weak value, weak quality, moderate sentiment.
A Trump family-linked investment group is placing a major wager on the future of public health screening at airports. American Ventures, an entity with ties to the former president's family, is investing $31.3 million in XWell Inc. (XWEL) to accelerate the deployment of its artificial intelligence-powered infectious disease screening systems across U.S. travel hubs, according to a report. The funding will specifically support the rollout of XWell's ConMRx platform, which uses thermal imaging and AI algorithms to detect elevated body temperatures and potential signs of illness in real-time. This technology is designed for seamless integration into existing airport security and checkpoint infrastructures. "This investment allows us to scale our solution at a critical time for national and global health security," said a company spokesperson. The deal underscores growing private sector interest in health-tech solutions for mass transit venues, particularly those with political connections that can facilitate government and public-sector contracts. XWell, which focuses on non-invasive health screening, has been actively pursuing partnerships with airports and government agencies since the onset of the COVID-19 pandemic. The backing from American Ventures provides a significant capital infusion and potentially influential advocacy as XWell seeks to formalize its systems within major U.S. airports.
Drafted by a large language model from the source reporting linked above, then screened by automated publishing checks. It is not read by a journalist before publication. Some articles cite our Alpha Score. Verify prices and figures against the original source. Educational coverage, not personalized advice.